Correction to: Ramos-Quiroga JA, Montoya A, Kutzelnigg A et al. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines. Curr Med Res Opin 2013;29:1-12
The authors have been made aware of the following errors:
1. On page 7, under the heading ‘Treatment of adult ADHD with atomoxetine’, both citations for reference 96 should instead have cited the below reference which was not included in the reference list:
Adler LA, Spencer T, Brown TE et al. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol 2009;29:44-50
2. On page 7, under the heading ‘Treatment of adult ADHD with atomoxetine’, the first sentence of the second paragraph was incorrect:
“Atomoxetine has a favorable profile for adult use because only one dose per day is required to achieve symptom relief across 24 hours.”
This should have read:
“Atomoxetine has a favorable profile for adult use because only one dose per day is required to achieve symptom relief.”
3. On page 8, under the heading ‘Stimulant versus atomoxetine use in adults’ the citation for reference 96 which appears in the last paragraph of the section should have instead cited the below reference which was not included in the reference list:
Adler LA, Liebowitz M, Kronenberger W et al. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 2009;26:212-21
4. On page 8, under the heading ‘Treatment of adult ADHD with atomoxetine’, the second paragraph of the section was incorrect:
“A potential benefit of atomoxetine, in comparison with stimulants, is that it relieves ADHD symptoms for a full 24 hours. In contrast, IR stimulants require multiple daily doses due to their short durations of action, and even ER stimulants may require twice daily dosing, as they control symptoms for only 6 to 14 hours12,18,23.”
This should have read:
“A potential benefit of atomoxetine is that a once daily morning dose relieves ADHD symptoms through the evening hours, while IR stimulants may require multiple daily doses12,18,23,119.”
These errors did not affect any of the study results or conclusions.